Search

Showing results for: AUTHOR - Anderson, MA

Found: 25 results

Immune recovery in patients with mantle cell lymphoma receiving long-term ibrutinib and venetoclax combination therapy Blood Adv - 2020-10-13 Davis, JE; Handunnetti, SM; Ludford-Menting, M; Sharpe, C; Blombery, P; Anderson, MA; Roberts, AW; Seymour, JF; Tam, CS; Ritchie, DS; Koldej, RM
Link to Open Access at Publisher's Site Download PDF
Tumor lysis syndrome: still the Achilles heel of venetoclax in treatment of CLL? Leukemia & Lymphoma - 2020-08-04 Anderson, MA; Seymour, JF
Link to Publisher's Version
BTK inhibitor therapy is effective in patients with CLL resistant to venetoclax Blood - 2020-04-03 Lin, VS; Lew, TE; Handunnetti, SM; Blombery, P; Nguyen, T; Westerman, DA; Kuss, BJ; Tam, C; Roberts, AW; Seymour, JF; Anderson, MA
Link to Open Access at Publisher's Site
Multiple BCL2 mutations co-occurring with Gly101Val emerge in chronic lymphocytic leukemia progression on venetoclax Blood - 2020-01-17 Blombery, P; Thompson, E; Nguyen, T; Birkinshaw, RW; Gong, J; Chen, X; McBean, M; Thijssen, R; Conway, T; Anderson, MA; Seymour, JF; Westerman, DA; Czabotar, PE; Huang, DCS; Roberts, AW
Link to Publisher's Version
Undetectable peripheral blood MRD should be the goal of venetoclax in CLL, but attainment plateaus after 24 months Blood Advances - 2020-01-14 Lew, TE; Anderson, MA; Lin, VS; Handunnetti, SM; Came, NA; Blombery, P; Westerman, DA; Wall, M; Tam, CS; Roberts, AW; Seymour, JF
Link to Open Access at Publisher's Site Download PDF
Structures of BCL-2 in complex with venetoclax reveal the molecular basis of resistance mutations Nature Communications - 2019-06-03 Birkinshaw, RW; Gong, JN; Luo, CS; Lio, D; White, CA; Anderson, MA; Blombery, P; Lessene, G; Majewski, IJ; Thijssen, R; Roberts, AW; Huang, DCS; Colman, PM; Czabotar, PE
Link to Open Access at Publisher's Site Download PDF
Acquisition of the recurrent Gly101Val mutation in BCL2 confers resistance to venetoclax in patients with progressive chronic lymphocytic leukemia Cancer Discovery - 2019-03 Blombery, P; Anderson, MA; Gong, JN; Thijssen, R; Birkinshaw, RW; Thompson, ER; Teh, CE; Nguyen, T; Xu, Z; Flensburg, C; Lew, TE; Majewski, IJ; Gray, DHD; Westerman, DA; Tam, CS; Seymour, JF; Czabotar, PE; Huang, DCS; Roberts, AW
Link to Publisher's Version
Dynamic molecular monitoring reveals that SWI-SNF mutations mediate resistance to ibrutinib plus venetoclax in mantle cell lymphoma Nature Medicine - 2018-11-19 Agarwal, R; Chan, YC; Tam, CS; Hunter, T; Vassiliadis, D; Teh, CE; Thijssen, R; Yeh, P; Wong, SQ; Ftouni, S; Lam, EYN; Anderson, MA; Pott, C; Gilan, O; Bell, CC; Knezevic, K; Blombery, P; Rayeroux, K; Zordan, A; Li, J; Huang, DCS; Wall, M; Seymour, JF; Gray, DHD; Roberts, AW; Dawson, MA; Dawson, SJ
Link to Publisher's Version
Ibrutinib plus Venetoclax for the Treatment of Mantle-Cell Lymphoma New England Journal of Medicine - 2018-03-29 Tam, CS; Anderson, MA; Pott, C; Agarwal, R; Handunnetti, S; Hicks, RJ; Burbury, K; Turner, G; Di Iulio, J; Bressel, M; Westerman, D; Lade, S; Dreyling, M; Dawson, SJ; Dawson, MA; Seymour, JF; Roberts, AW
Link to Publisher's Version
Phase I first-in-human study of venetoclax in patients with relapsed or refractory non-Hodgkin lymphoma J Clin Oncol - 2017-03-10 Davids, MS; Roberts, AW; Seymour, JF; Pagel, JM; Kahl, BS; Wierda, WG; Puvvada, S; Kipps, TJ; Anderson, MA; Salem, AH; Dunbar, M; Zhu, M; Peale, F; Ross, JA; Gressick, L; Desai, M; Kim, SY; Verdugo, M; Humerickhouse, RA; Gordon, GB; Gerecitano, JF
Link to Publisher's Version Link to PubMed Central Version
Venetoclax plus rituximab in relapsed or refractory chronic lymphocytic leukaemia: a phase 1b study Lancet Oncol - 2017-02 Seymour, JF; Ma, S; Brander, DM; Choi, MY; Barrientos, J; Davids, MS; Anderson, MA; Beaven, AW; Rosen, ST; Tam, CS; Prine, B; Agarwal, SK; Munasinghe, W; Zhu, M; Lash, LL; Desai, M; Cerri, E; Verdugo, M; Kim, SY; Humerickhouse, RA; Gordon, GB; Kipps, TJ; Roberts, AW
Link to Publisher's Version Link to PubMed Central Version
Clinico-pathological features and outcomes of progression of CLL on the BCL2 inhibitor venetoclax Blood - 2017 Anderson, MA; Tam, C; Lew, TE; Juneja, S; Juneja, M; Westerman, D; Wall, M; Lade, S; Gorelik, A; Huang, DCS; Seymour, JF; Roberts, AW
Link to Publisher's Version
Transformed lymphoma Hematol Oncol Clin North Am - 2016-12 Anderson, MA; Blombery, P; Seymour, JF
Link to Publisher's Version
The BCL2 selective inhibitor venetoclax induces rapid onset apoptosis of CLL cells in patients via a TP53 independent mechanism Blood - 2016-04-11 Anderson, MA; Deng, J; Seymour, JF; Tam, C; Kim, SY; Fein, J; Yu, L; Brown, JR; Westerman, D; Si, EG; Majewski, IJ; Segal, D; Heitner Enschede, SL; Huang, DC; Davids, MS; Letai, A; Roberts, AW
Link to Publisher's Version Link to PubMed Central Version
Current challenges and novel treatment strategies in double hit lymphomas Ther Adv Hematol - 2016-02 Anderson, MA; Tsui, A; Wall, M; Huang, DC; Roberts, AW
Link to Publisher's Version Link to PubMed Central Version
Targeting BCL2 with Venetoclax in relapsed chronic lymphocytic leukemia N Engl J Med - 2016-01-28 Roberts, AW; Davids, MS; Pagel, JM; Kahl, BS; Puvvada, SD; Gerecitano, JF; Kipps, TJ; Anderson, MA; Brown, JR; Gressick, L; Wong, S; Dunbar, M; Zhu, M; Desai, MB; Cerri, E; Enschede, SH; Humerickhouse, RA; Wierda, WG; Seymour, JF
Link to Publisher's Version
BCL2 inhibition in double hit lymphoma Leuk Lymphoma - 2015-07 Anderson, MA; Huang, DC; Roberts, AW
Link to Publisher's Version
Targeting BCL2 for the Treatment of Lymphoid Malignancies. Seminars in hematology - 2014-07 Anderson, MA; Huang, D; Roberts, A
Link to Open Access at Publisher's Site
BH3 mimetic therapy: an emerging and promising approach to treating chronic lymphocytic leukemia LEUKEMIA & LYMPHOMA - 2013-05 Anderson, MA; Huang, DCS; Roberts, AW
Link to Publisher's Version
Translation inhibitors induce cell death by multiple mechanisms and Mcl-1 reduction is only a minor contributor CELL DEATH & DISEASE - 2012-10 Lindqvist, LM; Vikstrom, I; Chambers, JM; McArthur, K; Anderson, MA; Henley, KJ; Happo, L; Cluse, L; Johnstone, RW; Roberts, AW; Kile, BT; Croker, BA; Burns, CJ; Rizzacasa, MA; Strasser, A; Huang, DCS
Link to Open Access at Publisher's Site
CHARACTERIZATION OF THE PROTEASE PROCESSING SITES IN A MULTIDOMAIN PROTEINASE-INHIBITOR PRECURSOR FROM NICOTIANA-ALATA EUROPEAN JOURNAL OF BIOCHEMISTRY - 1995-05-15 HEATH, RL; BARTON, PA; Simpson, RJ; Reid, GE; LIM, G; Anderson, MA
Link to Publisher's Version
PROTEINASE-INHIBITORS IN NICOTIANA-ALATA STIGMAS ARE DERIVED FROM A PRECURSOR PROTEIN WHICH IS PROCESSED INTO 5 HOMOLOGOUS INHIBITORS PLANT CELL - 1993-02 ATKINSON, AH; HEATH, RL; Simpson, RJ; Clarke, AE; Anderson, MA
STYLE SELF-INCOMPATIBILITY GENE-PRODUCTS OF NICOTIANA-ALATA ARE RIBONUCLEASES NATURE - 1989-12-21 MCCLURE, BA; HARING, V; EBERT, PR; Anderson, MA; Simpson, RJ; SAKIYAMA, F; Clarke, AE
Link to Publisher's Version
CLONING OF CDNA FOR A STYLAR GLYCOPROTEIN ASSOCIATED WITH EXPRESSION OF SELF-INCOMPATIBILITY IN NICOTIANA-ALATA NATURE - 1986-05-01 Anderson, MA; CORNISH, EC; MAU, SL; WILLIAMS, EG; HOGGART, R; ATKINSON, A; BONIG, I; GREGO, B; Simpson, R; ROCHE, PJ; HALEY, JD; PENSCHOW, JD; NIALL, HD; Tregear, GW; COGHLAN, JP; CRAWFORD, RJ; Clarke, AE
Link to Publisher's Version
STYLE PROTEINS OF A WILD TOMATO (LYCOPERSICON-PERUVIANUM) ASSOCIATED WITH EXPRESSION OF SELF-INCOMPATIBILITY PLANTA - 1986 MAU, SL; WILLIAMS, EG; ATKINSON, A; Anderson, MA; CORNISH, EC; GREGO, B; Simpson, RJ; KHEYRPOUR, A; Clarke, AE
Link to Publisher's Version

An error has occurred. This application may no longer respond until reloaded. Reload 🗙